InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Malady Kyle, Vice-Président Exécutif. Insider active across 2 companies, notably DEXCOM INC. Aggregated, 34 filings have been published. Split: 0 buy · 17 sells. Total volume traded: €6.2m. Activity tracked since 21 May 2021. The latest transaction was disclosed on 25 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Malady Kyle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations34 total
1,100 shares@ US$50.06Common StockSEC:0001760581-26-000046:0
1,100 shares@ US$48.680.0000% mcap0.8% of flowCommon StockSEC:0001760581-26-000044:0
5,575 shares0Common StockSEC:0001093557-26-000124:0
34,020 sharesCommon StockSEC:0001760581-26-000016:0
119,409 sharesCommon StockSEC:0001760581-26-000010:0
667 shares@ US$80.86100.0% of flowCommon StockSEC:0001093557-25-000253:0
5,192 shares0Common StockSEC:0001093557-25-000153:0
9,701 shares@ US$43.816.2% of flowCommon StockSEC:0001062993-25-008987:0
9,000 shares@ US$44.105.8% of flowCommon StockSEC:0001062993-25-008915:0
7,500 shares@ US$43.8754.8% of flowCommon StockSEC:0001062993-25-008301:0
10,000 shares@ US$43.0246.2% of flowCommon StockSEC:0001062993-25-008027:0
5,000 shares@ US$42.4853.1% of flowCommon StockSEC:0001062993-25-007882:0
19,678 sharesCommon StockSEC:0001062993-25-004305:0
6,590 shares@ US$39.704.2% of flowCommon StockSEC:0001062993-25-001791:0
8,000 shares@ US$39.8855.1% of flowCommon StockSEC:0001062993-25-001701:0
11,085 shares@ US$40.887.2% of flowCommon StockSEC:0001062993-25-001353:0
20,000 shares@ US$40.4912.8% of flowCommon StockSEC:0001062993-25-001263:0
20,000 shares@ US$40.5412.8% of flowCommon StockSEC:0001062993-25-001225:0
2,613 shares0Common StockSEC:0001093557-24-000118:0
15,085 sharesCommon StockSEC:0001062993-24-005350:0
24,000 shares@ US$40.8014.9% of flowCommon StockSEC:0001062993-24-004363:0
15,000 shares@ US$40.339.3% of flowCommon StockSEC:0001062993-24-003525:0
9,503 sharesCommon StockSEC:0001062993-24-003376:0
2,885 shares@ US$0.00152.6% of flowCommon StockSEC:0001093557-23-000136:0
6,226 shares@ US$36.693.5% of flowCommon StockSEC:0001062993-23-007117:0
25 of 34 declarations
About Malady Kyle
Malady Kyle is Executive Vice President. He has 32 filings in total, all within the tracked sample, and the recent observed transactions from 2021-05-25 to 2026-06-01 are all sales, for a total of EUR 6109000. The companies mentioned are Verizon Communications INC, where he is EVP and Group CEO-VZ Business, and DEXCOM INC, where he is Director.
